Morepen Laboratories & RDIF announce production of the test batch of Sputnik V in India

Morepen Laboratories & RDIF announce production of the test batch of Sputnik V in India

Ganesh V
/ Categories: Trending, Mindshare, DSIJ News

The Russian Direct Investment Fund (RDIF), and Morepen Laboratories, today announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in state of Himachal Pradesh (HP) 

To date, Sputnik V has been registered in 67 countries globally with a total population of over 3.5 bn people. 

Reacting to this, the company’s stock today increased by 15.30 per cent and made an intraday high of Rs 75 per share. The stock of the company has increased by 226 per cent from its decline in July 2020. 

Morepen is a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products in India since last 35 years. All the manufacturing facilities of the company are in the state of Himachal Pradesh. 

According to BSE data, the stock traded at a P/E multiple of 31.05 and a price-to-book ratio of 6.58. The stock has a 52-week high and a 52-week low of Rs 75 and Rs 19.30, respectively. 

At the time of market closing, the stock of the company was trading at Rs 71.50, up by 9.92 per cent on BSE.

Previous Article Overnight Digest: Small cap stocks to watch out for on July 7
Next Article BSE Private Banks Index Soars 1.39 percent; Top Gainer - AU Small Finance Bank Jumps 8.15 per cent; IDFC First Bank Top Loser
Rate this article:
4.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR